SCHEMBL23237381

SCHEMBL23237381

CC(C)(C)c1ccc2c(c1)C1(c3ccc(-c4cccc5ccccc45)cc3-c3ccc(N(c4ccccc4)c4ccc(-c5ccccc5)cc4)cc31)c1cc(C(C)(C)C)ccc1-2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.34
▸ PPARG P37231 3/20 0.33
▸ PPARA Q07869 3/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ SLC6A9 P48067 1/20 0.31
▸ CHRNA1 P02708 1/20 0.31
▸ CHRNG P07510 1/20 0.31
▸ CHRNB1 P11230 1/20 0.31
▸ CHRNB2 P17787 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ CHRNB4 P30926 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23238752 0.99 MCL1 (0.34) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL23238785 0.98 MCL1 (0.33) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL23237383 0.93 MCL1 (0.34) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL24817303 0.93 CA12 (0.34) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL26884559 0.93 PPARG (0.36) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL25121731 0.93 PPARG (0.36) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL23237003 0.93 PPARG (0.33) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL24817301 0.92 CA12 (0.33) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL23238784 0.92 MCL1 (0.34) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL26884534 0.92 CA12 (0.35) MCL1ACMSDPPARGPPARAGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
WO-2021070964-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, ELAVL1 MCL1 2421/4885ACMSD 777/4885PPARG 3345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback